(Q43407559)

23 November 2017

title

Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival (English)

1 reference

23 November 2017

0 references

3

Nancy Raab-Traub

1 reference

23 November 2017

Stephen A Wheless

1

1 reference

23 November 2017

Margaret L Gulley

2

1 reference

23 November 2017

Patrick McNeillie

4

1 reference

23 November 2017

Isabel P Neuringer

5

1 reference

23 November 2017

Hubert J Ford

6

1 reference

23 November 2017

Robert M Aris

7

1 reference

23 November 2017

language of work or name

English

0 references

publication date

28 August 2008

1 reference

American Journal of Respiratory and Critical Care Medicine

23 November 2017

published in

1 reference

23 November 2017

volume

178

1 reference

23 November 2017

issue

10

1 reference

23 November 2017

page(s)

1060-1065

1 reference

Post-transplant lymphoproliferative disorders

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Epstein-Barr virus: evasive maneuvers in the development of PTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Posttransplant lymphoproliferative disorder in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200804-531OC

10.1164/RCCM.200804-531OC

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference